Patterns in admission delays to outpatient methadone treatment in the United States
about
Use of pharmacotherapies in the treatment of alcohol use disorders and opioid dependence in primary careAdapting Screening, Brief Intervention, and Referral to Treatment for Alcohol and Drugs to Culturally Diverse Clinical PopulationsA review of a national training initiative to increase provider use of MAT to address the opioid epidemic.Mindfulness-based relapse prevention with racial and ethnic minority women.Offending, custody and opioid substitution therapy treatment utilisation among opioid-dependent people in contact with the criminal justice system: comparison of Indigenous and non-Indigenous AustraliansTreatment Outcomes of African American Buprenorphine Patients by Parole and Probation Status.Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system.Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study).Retention in methadone and buprenorphine treatment among African Americans.Accessibility versus quality of care plus retention: the formula for service delivery in Australian opioid replacement therapy?Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.Failure to get into substance abuse treatment.The Addiction Benefits Scorecard: A Framework to Promote Health Insurer Accountability and Support Consumer Engagement.Triage in opioid replacement therapy: what's the wait?Justice Involvement and Treatment Use Among Rural Veterans
P2860
Q28081029-CFD4004D-18A9-440F-B805-BF61443F8397Q28082595-0CC65555-190A-4494-BC2C-625FF28B328EQ30239840-B94C37BA-0C03-49BA-BAC9-EE32C286297CQ33719632-2A421CF2-E33E-49A2-955D-C7297581595CQ34207684-DD4FFD32-87C4-46CE-A10E-9B1AD3EE15E3Q34425700-74F69FC3-894D-4995-BBA7-7DD7986E9CB6Q34432627-8CB0E6C8-1A4A-4ACE-866D-3A652518DE95Q36619578-24D471AB-D1B3-475B-AE92-652FF6B64537Q36711790-271DC6B9-A3BF-4FE8-8E88-A2DC5904D246Q36769571-135DAF3F-975D-462A-A738-5E61818DA63CQ37022122-57ACADED-678C-4181-B9E8-BE59F391066DQ38134149-E8D7FD9D-F37F-4254-AD89-19B017DD1FD0Q38673634-3E7D101F-B097-4F36-9E3C-F7591DEE83FDQ38778282-E0DA4B5F-060A-4CA0-879A-D5530287523EQ38901184-662BFB32-0DBE-493D-AF77-374CFDCA3EB4Q40073213-A699C995-9617-466B-BA2C-A41CED8C8973Q57150730-FF0E5687-6957-45F4-B6B5-4C331C705423
P2860
Patterns in admission delays to outpatient methadone treatment in the United States
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Patterns in admission delays to outpatient methadone treatment in the United States
@ast
Patterns in admission delays to outpatient methadone treatment in the United States
@en
type
label
Patterns in admission delays to outpatient methadone treatment in the United States
@ast
Patterns in admission delays to outpatient methadone treatment in the United States
@en
prefLabel
Patterns in admission delays to outpatient methadone treatment in the United States
@ast
Patterns in admission delays to outpatient methadone treatment in the United States
@en
P2093
P2860
P1476
Patterns in admission delays to outpatient methadone treatment in the United States
@en
P2093
David S Salkever
Jan Gryczynski
Jerome H Jaffe
Robert P Schwartz
Shannon Gwin Mitchell
P2860
P304
P356
10.1016/J.JSAT.2011.06.005
P577
2011-08-06T00:00:00Z